Clopidogrel Bisulfate (molecular weight approximately 419.9) is a platelet aggregation inhibitor belonging to the thienopyridine class. As a prodrug, it needs to be metabolized and converted into its active form in the liver. It irreversibly inhibits the ADP receptors on the platelet surface, preventing platelet activation and aggregation, thereby preventing thrombus formation. It is suitable for preventing atherosclerotic thrombotic events in patients with recent myocardial infarction, recent ischemic stroke, etc.
Clopidogrel Bisulfate is an irreversible P2Y12 platelet aggregation inhibitor, whose core efficacy is to inhibit platelet activation and aggregation. Clinically, it is mainly used for thrombosis prevention and treatment in cardiovascular and cerebrovascular diseases: including acute coronary syndrome (ACS), percutaneous coronary intervention (PCI), ischemic stroke/transient ischemic attack (TIA), and peripheral arterial disease. It is particularly suitable for patients intolerant to aspirin or those requiring enhanced antithrombotic therapy.
Frequently Asked Questions
What is the primary function of Clopidogrel Bisulfate?
It acts as a platelet aggregation inhibitor, primarily used to prevent thrombus formation in cardiovascular and cerebrovascular diseases.
What is the purity level of your Clopidogrel Bisulfate powder?
Our product maintains a high purity level of over 99%, tested via HPLC method.
How should the product be stored?
It should be stored at room temperature (RT) in a cool, dry place away from direct sunlight.
What certifications does this material have?
It is compliant with GMP, HSE, ISO 9001, USP, and BP standards.
Who is the target demographic for this pharmaceutical material?
It is suitable for the production of medications intended for adults, children, and the elderly.
Can I request a Certificate of Analysis (COA)?
Yes, every batch is strictly tested, and a detailed COA is provided to ensure quality compliance.